Literature DB >> 29571629

Partial retinal photoreceptor loss in a transgenic mouse model associated with reduced levels of interphotoreceptor retinol binding protein (IRBP, RBP3).

Yi-Hsia Liu1, Clare Corbett2, Izabela P Klaska3, Kimmo Makinen4, John M Nickerson5, Richard J Cornall6, Lucia Kuffova7, John V Forrester8.   

Abstract

Organ-specific transgenic membrane expression of hen egg lysozyme (HEL) as a "neo-self antigen" has been used in several models to study immunological tolerance. In this study we report the changes which occur in the B10.BR mouse retina when membrane-bound HEL is expressed in photoreceptors under the control of the promoter for interphotoreceptor retinoid binding protein (IRBP, RBP3). On direct clinical examination of the single transgenic (sTg-IRBP:HEL) mouse fundus, a low-level increase in retinal degeneration compared to non-transgenic controls was observed, presenting as drusenoid deposits and occasional small patches of atrophy. On histological examination, there was an overall shortening of outer segments and loss of photoreceptor nuclei in sTg-IRBP:HEL mice, which was more pronounced in the retinal periphery, particularly inferiorly. The fundoscopically observed lesions did not correlate with the photoreceptor shortening/loss but appeared to be located at the level of the retinal pigment epithelium/choriocapillaris layer and were an exaggeration in size and number of similar age-related changes found in wild type (WT) mice. In addition, neither the atrophic lesions nor the photoreceptor shortening were associated with common retinal degeneration genes, nor were they caused by exposure to light damage since mice housed at both high and low ambient light levels had similar degrees of retinal degeneration. Instead, sTg-IRBP:HEL mice expressed reduced levels of soluble retinal IRBP compared to WT mice which were present from postnatal day16 (P16) and preceded development of photoreceptor shortening (onset P21). We propose that insertion of the HEL transgene in the photoreceptor membrane disrupted normal photoreceptor function and led to reduced levels of soluble IRBP and retinal thinning. A similar phenotype has been observed in IRBP deficient mice. Despite the retinal thinning, the amount of HEL expressed in the retina was sufficient to act as an autoantigenic target when the mice were crossed to the HEL T cell receptor Tg mouse, since double transgenic (dTg-IRBP:HEL) mice spontaneously developed a severe uveoretinitis with onset at weaning. We suggest that, although membrane expression of foreign transgene products is likely to modify the structure and function of tissues and cells, the technology provides useful models to investigate mechanisms of antigen-specific immunological tolerance.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EAU; Hen egg lysozyme (HEL); Photoreceptor; Retinal degeneration; Transgenic

Mesh:

Substances:

Year:  2018        PMID: 29571629     DOI: 10.1016/j.exer.2018.03.020

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  RBP3: a possible prognostic marker and therapeutic target in diabetic retinopathy.

Authors:  Dario Rusciano; Paola Bagnoli
Journal:  Ann Transl Med       Date:  2019-12

2.  Ferroptosis and Apoptosis Are Involved in the Formation of L-Selenomethionine-Induced Ocular Defects in Zebrafish Embryos.

Authors:  Meng Gao; Jun Hu; Yuejie Zhu; Xianqing Wang; Shumin Zeng; Yijiang Hong; Guang Zhao
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

3.  Transmission Electron Microscopy Data on drusen-like deposits in the retinal degeneration sTg-IRBP: HEL mouse model.

Authors:  Yi-Hsia Liu; Christine Mölzer; Gillian C Milne; Lucia Kuffová; John V Forrester
Journal:  Data Brief       Date:  2018-12-06

4.  Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.

Authors:  Yi-Hsia Liu; Christine Mölzer; Kimmo Makinen; Koju Kamoi; Clare L C Corbett; Izabela P Klaska; Delyth M Reid; Heather M Wilson; Lucia Kuffová; Richard J Cornall; John V Forrester
Journal:  Front Immunol       Date:  2020-09-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.